CVS CVS Health Corporation
Healthcare$90.73-2.71%ClosedMarket Cap: $115.76B
As of 2026-05-26
Valuation
P/E (TTM)
57.08
PEG
—
P/B
1.53
P/S
0.29
EV/EBITDA
16.87
DCF Value
$383.88
FCF Yield
6.2%
Div Yield
2.9%
Margins & Returns
Gross Margin
13.9%
Operating Margin
1.5%
Net Margin
0.7%
ROE
3.9%
ROA
1.2%
ROIC
2.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $100.43B | 15.6% | $4.68B | $2.94B | $— | $0.67 |
| Q4 null | $105.69B | 12.8% | $2.11B | $2.94B | $— | $0.67 |
| FY null | $402.07B | 13.8% | $10.38B | $1.77B | $— | $2.66 |
| Q3 null | $102.87B | 13.4% | $-3.21B | $-3.98B | $— | $0.67 |
| Q2 null | $98.92B | 13.7% | $2.38B | $1.02B | $— | $0.67 |
| Q1 null | $94.59B | 15.2% | $3.37B | $1.78B | $— | $0.67 |
| Q4 null | $97.71B | 13.2% | $2.37B | $1.64B | $— | $0.67 |
| FY null | $372.81B | 13.8% | $8.52B | $4.61B | $— | $2.66 |
| Q3 null | $95.43B | 13.2% | $832.0M | $87.0M | $— | $0.67 |
| Q2 null | $91.23B | 14.7% | $3.04B | $1.77B | $— | $0.67 |
| Q1 null | $88.44B | 14.2% | $2.27B | $1.11B | $— | $0.67 |
| Q4 2023 | $93.81B | 14.8% | $3.37B | $2.05B | $1.59 | $0.61 |